Regenxbio (RGNX) Net Margin (2014 - 2025)

Regenxbio's (RGNX) quarterly Net Margin came in at 330.86% in Q4 2025, up 64489.0% year-on-year from N/an in Q4 2024, and up 250.23% quarter-over-quarter from 220.23% in Q3 2025.

Regenxbio (RGNX) Net Margin (2014 - 2025) Analysis & Trends

Regenxbio's Net Margin history runs 12 years deep, the most recent figure standing at 330.86% for Q4 2025.

  • On a quarterly basis, Net Margin rose 64489.0% year-over-year to 330.86% in Q4 2025; TTM through Dec 2025 was 26.03%, a 28240.0% increase from a year earlier, with the FY2025 full-year figure at 342.72%, down 6598.0% from the prior year.
  • Net Margin grew to 330.86% in Q4 2025 per RGNX's latest filing, from 220.23% in the prior quarter.
  • Across five years, Net Margin topped out at 890.75% in Q4 2022 and bottomed at 481.95% in Q1 2024.
  • The 5-year median for Net Margin is 254.98% (2021), against an average of 165.35%.
  • Across the five-year window, Net Margin surged 81700 bps in 2022 and plunged 117423 bps in 2023, its largest moves.
  • Year by year, Net Margin stood at 73.75% in 2021, then soared by 1108 bps to 890.75% in 2022, then plunged by 132 bps to 283.48% in 2023, then declined by 11 bps to 314.04% in 2024, then soared by 205 bps to 330.86% in 2025.
  • Per Business Quant, the three latest RGNX Net Margin figures stand at 330.86% (Q4 2025), 220.23% (Q3 2025), and 331.91% (Q2 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 15.02%
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 34.53%
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 20.17%
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 30.33%
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Regenxbio 528.62 Mn 298.55 Mn 21.22 Mn 330.86%

Historic Data

Download Data
DateValue
Dec 31, 2025 330.86%
Sep 30, 2025 -220.23%
Jun 30, 2025 -331.91%
Mar 31, 2025 4.06%
Dec 31, 2024 -314.04%
Sep 30, 2024 -248.39%
Jun 30, 2024 -247.60%
Mar 31, 2024 -481.95%
Dec 31, 2023 -283.48%
Sep 30, 2023 -213.97%
Jun 30, 2023 -360.72%
Mar 31, 2023 -348.40%
Dec 31, 2022 890.75%
Sep 30, 2022 -284.72%
Jun 30, 2022 -208.82%
Mar 31, 2022 -345.32%
Dec 31, 2021 73.75%
Sep 30, 2021 -189.79%
Jun 30, 2021 -261.58%
Mar 31, 2021 -265.51%